Form 4: TELA Bio, Inc. Chief Accounting Officer Reports Stock Transaction
SEC Form 4 Filing
Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports the disposition of 96 shares of common stock to cover withholding taxes upon vesting of restricted stock units on March 31, 2024.
Summary
- On March 31, 2024, Megan Smeykal, the Chief Accounting Officer and Controller of TELA Bio, Inc., disposed of 96 shares of common stock.
- The transaction was executed to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- The shares were disposed of at a price of $5.67 per share.
- Following the transaction, Ms. Smeykal directly owns 29,000 shares of TELA Bio, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard tax-related transaction. It doesn't indicate positive or negative sentiment towards the company.
Industry Context
This is a routine Form 4 filing, reflecting a common practice where company shares are used to cover tax obligations arising from the vesting of equity compensation.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of stock transaction (disposition of shares). |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.